Beurs gesloten -
Bombay S.E.
12:00:52 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
739
INR
|
-1,35%
|
|
+2,74%
|
+35,41%
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
130.784
|
103.465
|
39.635
|
108.375
|
61.740
|
44.418
|
Bedrijfswaarde
1 |
162.769
|
138.045
|
73.537
|
129.776
|
83.768
|
70.861
|
K/w-verhouding
|
20,4
x
|
18
x
|
4,41
x
|
13
x
|
14,9
x
|
-72,8
x
|
Dividendrendement
|
0,36%
|
0,68%
|
2,01%
|
0,73%
|
1,29%
|
1,79%
|
Marktkapitalisatie/omzet
|
1,74
x
|
1,14
x
|
0,43
x
|
1,78
x
|
1,01
x
|
0,71
x
|
Bedrijfswaarde/omzet
|
2,17
x
|
1,52
x
|
0,8
x
|
2,13
x
|
1,37
x
|
1,13
x
|
Bedrijfswaarde/EBITDA
|
11,2
x
|
8,29
x
|
4,1
x
|
8,84
x
|
7,86
x
|
11
x
|
Bedrijfswaarde/FCF
|
38,8
x
|
193
x
|
17,8
x
|
12,3
x
|
181
x
|
-50,8
x
|
FCF Yield
|
2,58%
|
0,52%
|
5,61%
|
8,11%
|
0,55%
|
-1,97%
|
Price to Book
|
3,2
x
|
2,2
x
|
0,71
x
|
2,28
x
|
1,16
x
|
0,82
x
|
Aantal aandelen (in duizenden)
|
155.732
|
155.774
|
159.272
|
159.281
|
159.206
|
159.174
|
Referentieprijs
2 |
839,8
|
664,2
|
248,8
|
680,4
|
387,8
|
279,0
|
Datum van publicatie
|
31/08/18
|
31/08/19
|
19/08/20
|
30/08/21
|
3/09/22
|
8/08/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
75.178
|
91.108
|
91.544
|
60.985
|
61.302
|
62.817
|
EBITDA
1 |
14.477
|
16.643
|
17.944
|
14.676
|
10.663
|
6.462
|
Bedrijfsresultaat (EBIT)
1 |
11.985
|
13.926
|
15.183
|
11.443
|
8.398
|
3.749
|
Operationele Marge
|
15,94%
|
15,29%
|
16,59%
|
18,76%
|
13,7%
|
5,97%
|
Resultaat voor belastingen (EBT)
1 |
8.591
|
9.038
|
12.105
|
8.711
|
6.304
|
277,8
|
Nettowinst (verlies)
1 |
6.428
|
5.745
|
8.982
|
8.359
|
4.139
|
-609,8
|
Nettomarge
|
8,55%
|
6,31%
|
9,81%
|
13,71%
|
6,75%
|
-0,97%
|
WPA
2 |
41,25
|
36,86
|
56,39
|
52,48
|
26,00
|
-3,832
|
Free Cash Flow
1 |
4.196
|
715,8
|
4.124
|
10.523
|
463,4
|
-1.396
|
FCF-marge
|
5,58%
|
0,79%
|
4,5%
|
17,25%
|
0,76%
|
-2,22%
|
Kasstroomconversie (ebitda)
|
28,98%
|
4,3%
|
22,98%
|
71,7%
|
4,35%
|
-
|
Kasstroomconversie (nettowinst)
|
65,28%
|
12,46%
|
45,91%
|
125,89%
|
11,19%
|
-
|
Dividend per aandeel
2 |
3,000
|
4,500
|
5,000
|
5,000
|
5,000
|
5,000
|
Datum van publicatie
|
31/08/18
|
31/08/19
|
19/08/20
|
30/08/21
|
3/09/22
|
8/08/23
|
Fiscaal tijdperk: Maart |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Omzet
1 |
26.643
|
19.734
|
16.346
|
16.574
|
13.105
|
15.275
|
14.517
|
15.995
|
15.525
|
EBITDA
1 |
4.928
|
3.746
|
3.880
|
3.395
|
1.942
|
2.474
|
1.924
|
2.188
|
1.459
|
Bedrijfsresultaat (EBIT)
1 |
3.968
|
2.884
|
2.872
|
2.397
|
1.009
|
1.468
|
977,3
|
1.248
|
516
|
Operationele Marge
|
14,89%
|
14,61%
|
17,57%
|
14,46%
|
7,7%
|
9,61%
|
6,73%
|
7,8%
|
3,32%
|
Resultaat voor belastingen (EBT)
1 |
3.432
|
3.236
|
2.465
|
2.080
|
702
|
1.043
|
692,1
|
390,6
|
103,8
|
Nettowinst (verlies)
1 |
3.099
|
2.139
|
1.605
|
1.426
|
509,9
|
595,5
|
470,4
|
54,9
|
-156,7
|
Nettomarge
|
11,63%
|
10,84%
|
9,82%
|
8,61%
|
3,89%
|
3,9%
|
3,24%
|
0,34%
|
-1,01%
|
WPA
|
19,46
|
-
|
10,09
|
8,970
|
-
|
3,740
|
-
|
0,3400
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
5/02/21
|
4/06/21
|
23/07/21
|
22/10/21
|
4/02/22
|
27/05/22
|
2/08/22
|
21/10/22
|
3/02/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
31.985
|
34.580
|
33.902
|
21.401
|
22.028
|
26.443
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,209
x
|
2,078
x
|
1,889
x
|
1,458
x
|
2,066
x
|
4,092
x
|
Free Cash Flow
1 |
4.196
|
716
|
4.124
|
10.523
|
463
|
-1.396
|
ROE (netto-inkomsten/eigen vermogen)
|
17,1%
|
13%
|
17,3%
|
11,1%
|
8,21%
|
-1,21%
|
ROA (netto-inkomsten/totale activa)
|
8,03%
|
8,26%
|
7,91%
|
6,67%
|
5,55%
|
2,22%
|
Totale activa
1 |
80.061
|
69.583
|
113.544
|
125.293
|
74.559
|
-27.521
|
Nettoactief per aandeel
2 |
262,0
|
302,0
|
352,0
|
298,0
|
334,0
|
339,0
|
Cashflow per aandeel
2 |
15,70
|
63,10
|
77,30
|
31,50
|
61,80
|
63,70
|
Capex
1 |
4.891
|
6.559
|
5.742
|
5.275
|
6.000
|
8.144
|
Capex/omzet
|
6,51%
|
7,2%
|
6,27%
|
8,65%
|
9,79%
|
12,97%
|
Datum van publicatie
|
31/08/18
|
31/08/19
|
19/08/20
|
30/08/21
|
3/09/22
|
8/08/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +35,41% | 1,41 mld. | | +55,32% | 815 mld. | | +44,05% | 641 mld. | | -6,75% | 352 mld. | | +13,56% | 314 mld. | | +10,68% | 303 mld. | | +16,57% | 242 mld. | | +13,31% | 218 mld. | | +8,48% | 168 mld. | | -2,81% | 159 mld. |
Farmaceutische producten - Andere
|